NYSE:TARO
Taro Pharmaceutical Industries
- Stock
Last Close
42.97
21/06 19:59
Market Cap
1.62B
Beta: 0.70
Volume Today
147.06K
Avg: 16.05K
PE Ratio
34.88
PFCF: 18.53
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Mar '15 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | Mar '24 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 118.96M - | 129.41M 8.79% | 139.80M 8.03% | 142.82M 2.16% | 146.34M 2.46% | 150.58M 2.90% | 166.68M 10.70% | 195.37M 17.21% | 218.55M 11.87% | 215.74M 1.29% | |
average payables | 275.21M - | 277.28M 0.75% | 227.65M 17.90% | 117.77M 48.27% | 30.38M 74.20% | 31.96M 5.20% | 45.01M 40.84% | 64.70M 43.74% | 68.36M 5.66% | 56.57M 17.24% | |
average receivables | 387.25M - | 491.34M 26.88% | 489.77M 0.32% | 399.81M 18.37% | 307.36M 23.12% | 278.05M 9.54% | 268.84M 3.31% | 286.79M 6.68% | 283.08M 1.29% | 218.47M 22.83% | |
book value per share | 32.96 - | 45.09 36.80% | 50.06 11.03% | 54.92 9.70% | 48.87 11.01% | 54.70 11.93% | 44.59 18.49% | 45.47 1.98% | 46.05 1.29% | 47.71 3.59% | |
capex per share | -0.47 - | -0.45 4.17% | -0.87 94.08% | -0.74 15.04% | -0.79 6.99% | -0.74 6.19% | -0.45 39.22% | -0.32 28.72% | -0.47 48.46% | ||
capex to depreciation | -1.26 - | -1.29 1.96% | -2.41 87.38% | -1.79 25.74% | -1.65 7.85% | -1.33 19.52% | -0.72 45.48% | -0.46 35.83% | -0.56 19.58% | ||
capex to operating cash flow | -0.05 - | -0.05 1.35% | -0.08 69.00% | -0.09 11.66% | -0.09 3.88% | -0.10 10.28% | -0.37 258.31% | 0.08 120.25% | -0.56 840.97% | ||
capex to revenue | -0.02 - | -0.02 13.02% | -0.04 102.33% | -0.04 9.75% | -0.05 2.65% | -0.04 3.86% | -0.03 29.08% | -0.02 31.33% | -0.03 45.24% | ||
cash per share | 21.48 - | 28.68 33.55% | 33.58 17.06% | 35.43 5.51% | 26.91 24.04% | 28.83 7.12% | 26.79 7.07% | 21.80 18.61% | 22.62 3.75% | 23.40 3.42% | |
days of inventory on hand | 235.56 - | 294.39 24.97% | 247.35 15.98% | 266.01 7.54% | 241.11 9.36% | 228.01 5.43% | 260.81 14.39% | 286.36 9.80% | 271.59 5.16% | 230.59 15.10% | |
days payables outstanding | 605.39 - | 521.55 13.85% | 367.98 29.44% | 47.27 87.15% | 57.09 20.76% | 42.98 24.70% | 88.48 105.85% | 92.85 4.93% | 82.06 11.62% | 50.28 38.72% | |
days sales outstanding | 200.21 - | 195.54 2.33% | 195.16 0.19% | 181.65 6.92% | 155.45 14.42% | 153.29 1.39% | 177.45 15.76% | 199.42 12.38% | 165.30 17.11% | 102.95 37.72% | |
debt to assets | 0.00 - | -0.03 930.04% | -0.02 16.09% | -0.00 90.63% | 0.01 394.18% | -0.00 116.90% | -0.00 63.09% | 0.00 349.48% | -0.00 161.08% | ||
debt to equity | 0.00 - | -0.03 864.02% | -0.03 17.98% | -0.00 90.66% | 0.01 398.76% | -0.00 116.78% | -0.00 53.15% | 0.00 324.56% | -0.00 159.26% | ||
dividend yield | 0.12 - | ||||||||||
earnings yield | 0.08 - | 0.09 9.98% | 0.09 7.47% | 0.05 43.31% | 0.07 23.58% | 0.10 56.33% | -0.14 237.05% | 0.04 125.16% | 0.03 22.21% | 0.03 21.92% | |
enterprise value | 5.57B - | 5.56B 0.11% | 4.22B 24.16% | 3.35B 20.43% | 3.68B 9.63% | 1.84B 49.92% | 2.21B 20.23% | 1.38B 37.71% | 761.52M 44.79% | 1.22B 60.77% | |
enterprise value over ebitda | 11.28 - | 8.91 21.04% | 8.27 7.10% | 9.43 13.98% | 13.04 38.24% | 7.28 44.17% | 3.04 58.21% | 6.56 115.69% | 14.46 120.47% | 39.37 172.25% | |
ev to operating cash flow | 13.68 - | 14.07 2.84% | 9.64 31.51% | 10.36 7.55% | 11.36 9.63% | 6.78 40.31% | 48.38 613.45% | -8.69 117.97% | 23.98 375.94% | ||
ev to sales | 6.45 - | 5.85 9.34% | 4.79 18.00% | 5.07 5.71% | 5.49 8.33% | 2.86 47.97% | 4.03 41.21% | 2.46 39.08% | 1.33 45.91% | 1.95 46.40% | |
free cash flow per share | 9.03 - | 8.78 2.80% | 9.73 10.81% | 7.33 24.70% | 7.52 2.59% | 6.32 15.86% | 0.75 88.15% | -4.54 705.46% | 0.37 108.16% | ||
free cash flow yield | 0.06 - | 0.06 4.30% | 0.08 36.12% | 0.07 10.30% | 0.07 7.75% | 0.10 49.70% | 0.01 90.17% | -0.10 1,132.19% | 0.02 114.51% | ||
graham net net | 23.69 - | 33.36 40.83% | 38.59 15.68% | 37.83 1.97% | 28.55 24.54% | 30.08 5.36% | 15.77 47.57% | 18.36 16.42% | 20.05 9.21% | 29.45 46.89% | |
graham number | 91.56 - | 113.19 23.62% | 111.56 1.44% | 80.61 27.75% | 89.15 10.59% | 88.41 0.83% | 102.57 16.02% | 39.79 61.20% | 26.49 33.44% | 39.22 48.09% | |
income quality | 0.84 - | 0.73 12.99% | 0.96 31.25% | 1.54 60.82% | 1.15 25.53% | 1.11 3.21% | -0.11 110.28% | -2.72 2,284.72% | 1.25 145.81% | ||
intangibles to total assets | 0.01 - | 0.01 15.06% | 0.01 12.56% | 0.01 2.62% | 0.01 20.14% | 0.01 10.87% | 0.01 9.05% | 0.03 194.93% | 0.01 75.59% | 0.01 1.23% | |
interest coverage | 568.57 - | 1.30K 128.48% | 3.93K 202.59% | 996.74 74.64% | 1.16K 16.08% | 340.05 70.61% | 516.83 51.99% | 111.53 78.42% | -1.00 100.90% | ||
interest debt per share | 0.16 - | -1.43 995.92% | -1.31 8.45% | -0.13 90.31% | 0.36 386.98% | -0.05 113.25% | 0.01 121.00% | 0.10 914.33% | -0.51 593.53% | ||
inventory turnover | 1.55 - | 1.24 19.98% | 1.48 19.02% | 1.37 7.02% | 1.51 10.33% | 1.60 5.75% | 1.40 12.58% | 1.27 8.92% | 1.34 5.44% | 1.58 17.78% | |
invested capital | 0.00 - | -0.03 864.02% | -0.03 17.98% | -0.00 90.66% | 0.01 398.76% | -0.00 116.78% | -0.00 53.15% | 0.00 324.56% | -0.00 159.26% | ||
market cap | 6.04B - | 6.14B 1.57% | 4.82B 21.50% | 3.93B 18.38% | 4.25B 7.99% | 2.35B 44.56% | 2.82B 19.72% | 1.63B 42.22% | 914.06M 43.87% | 1.59B 73.64% | |
net current asset value | 1.19B - | 1.63B 36.30% | 1.78B 9.61% | 1.67B 6.13% | 1.26B 24.81% | 1.30B 3.38% | 759.42M 41.63% | 872.97M 14.95% | 931.77M 6.74% | 1.30B 39.03% | |
net debt to ebitda | -0.96 - | -0.92 4.17% | -1.18 27.50% | -1.62 37.58% | -2.01 24.09% | -2.02 0.55% | -0.83 59.02% | -1.18 42.83% | -2.90 144.73% | -11.67 302.86% | |
net income per share | 11.31 - | 12.63 11.71% | 11.05 12.51% | 5.26 52.41% | 7.23 37.44% | 6.35 12.13% | -10.49 265.15% | 1.55 114.76% | 0.68 56.27% | 1.43 111.70% | |
operating cash flow per share | 9.50 - | 9.23 2.86% | 10.59 14.84% | 8.06 23.91% | 8.30 2.99% | 7.06 14.94% | 1.20 83.04% | -4.22 451.97% | 0.84 120.04% | ||
payables turnover | 0.60 - | 0.70 16.08% | 0.99 41.73% | 7.72 678.40% | 6.39 17.19% | 8.49 32.80% | 4.13 51.42% | 3.93 4.70% | 4.45 13.15% | 7.26 63.19% | |
receivables turnover | 1.82 - | 1.87 2.39% | 1.87 0.19% | 2.01 7.44% | 2.35 16.85% | 2.38 1.41% | 2.06 13.61% | 1.83 11.02% | 2.21 20.65% | 3.55 60.56% | |
research and ddevelopement to revenue | 0.08 - | 0.07 1.41% | 0.08 7.33% | 0.11 32.43% | 0.09 11.27% | 0.09 1.79% | 0.11 18.19% | 0.10 11.33% | 0.09 6.15% | 0.10 12.49% | |
return on tangible assets | 0.28 - | 0.25 11.13% | 0.20 19.52% | 0.09 56.47% | 0.13 52.42% | 0.11 21.07% | -0.17 259.42% | 0.03 116.44% | 0.01 56.62% | 0.03 109.08% | |
revenue per share | 20.15 - | 22.20 10.18% | 21.29 4.08% | 16.48 22.58% | 17.18 4.23% | 16.76 2.42% | 14.37 14.30% | 14.91 3.80% | 15.24 2.22% | 16.74 9.81% | |
roe | 0.34 - | 0.28 18.34% | 0.22 21.20% | 0.10 56.62% | 0.15 54.43% | 0.12 21.49% | -0.24 302.62% | 0.03 114.47% | 0.01 56.82% | 0.03 104.36% | |
roic | 0.31 - | 0.28 10.06% | 0.21 25.42% | 0.10 52.44% | 0.12 23.06% | 0.10 21.14% | 0.42 340.26% | 0.08 81.01% | 0.01 91.53% | ||
sales general and administrative to revenue | 0.09 - | 0.10 - | 0.15 46.10% | ||||||||
shareholders equity per share | 32.96 - | 45.09 36.80% | 50.06 11.03% | 54.92 9.70% | 48.87 11.01% | 54.70 11.93% | 44.59 18.49% | 45.47 1.98% | 46.05 1.29% | 47.71 3.59% | |
stock based compensation to revenue | 0.07 - | -0.01 118.53% | -0.03 158.88% | 0.05 260.13% | |||||||
tangible asset value | 1.40B - | 1.91B 36.55% | 2.05B 7.30% | 2.18B 6.63% | 1.88B 13.78% | 2.08B 10.59% | 1.67B 19.82% | 1.64B 1.74% | 1.71B 4.52% | 2.14B 24.70% | |
tangible book value per share | 32.61 - | 44.54 36.55% | 49.56 11.27% | 54.35 9.67% | 48.26 11.21% | 54.11 12.12% | 43.67 19.29% | 43.56 0.25% | 43.57 0.03% | 56.85 30.50% | |
working capital | 1.20B - | 1.63B 35.58% | 1.79B 9.62% | 1.68B 6.05% | 1.27B 24.69% | 1.31B 3.47% | 794.53M 39.34% | 905.77M 14.00% | 950.88M 4.98% | 942.30M 0.90% |
All numbers in USD (except ratios and percentages)